The Latest Breaking News from Disease

With vast potential, contribution to rare disease discovery and management, and adoption of AI, the genomic research market is thriving. Hence, fundamentally solid genomic research stocks Agilent Technologies (A), Illumina (ILMN), and 10x Genomics (TXG) could be ideal buys. Read more.

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged – treatment with steroids, such as prednisolone.

As chronic and infectious diseases continue to rise, the demand for advanced healthcare solutions grows. Hence, investing in established healthcare stocks, Pfizer (PFE), Merck & Co (MRK), and AbbVie (ABBV), presents a compelling opportunity to capitalize on the sector’s landscape. Read on….

Growing rates of infectious disease in state’s most populous region could indicate increased ‘vaccine hesitancy’

Could hitting specific numerical targets help supercharge weight loss and protect you from chronic disease? Nutritionist Louise Pyne investigates…

Actor was seen smiling with daughters while holding plaque that reads ‘Best Dad Ever’

We highlight a great visual primer on a disease the WHO has declared a public health emergency

India Block speaks to paediatrician and TV writer Dr Neal Baer about the controversial technology and how it could reshape humanity

Burrow lost his battle against motor neurone disease in June aged 41.

There were just three cases of meningococcal group C – the infection which can lead to meningitis C – last year, the UK Health Security Agency said.

Fibrodysplasia ossificans progressiva (FOP) is an extremely rare congenital condition that causes the body to grow a second skeleton, rendering patients immobile.